AIP
ATOS icon

Ameritas Investment Partners’s Atossa Therapeutics ATOS Stock Holding History

Ameritas Investment Partners’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-826
Closed -$8.34K – 3211
2025
Q1 		$8.34K Hold
826
– – ﹤0.01% 2873
2024
Q4 		$11.7K Hold
826
– – ﹤0.01% 2861
2024
Q3 		$18.8K Hold
826
– – ﹤0.01% 2689
2024
Q2 		$14.7K Buy
+826
New +$18.3K ﹤0.01% 2751
2022
Q2 		– Sell
-612
Closed -$11K – 3074
2022
Q1 		$11K Hold
612
– – ﹤0.01% 2750
2021
Q4 		$15K Hold
612
– – ﹤0.01% 2756
2021
Q3 		$30K Hold
612
– – ﹤0.01% 2465
2021
Q2 		$58K Buy
+612
New +$32.4K ﹤0.01% 2090

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameritas Investment Partners's ATOS Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Atossa Therapeutics (ATOS) in Q2 2025, closing a stake of 826 shares — an estimated $8.34K sold.

Ameritas Investment Partners first reported a position in ATOS in Q2 2021 and held it in 8 quarters. The position peaked at $58K in Q2 2021. 84 funds tracked by Wall St. Rank hold ATOS as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Atossa Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 826 Atossa Therapeutics shares in Q2 2025, an estimated $8.34K.
  • Ameritas Investment Partners first reported a position in Atossa Therapeutics in Q2 2021 and held it in 8 quarters.
  • Ameritas Investment Partners's Atossa Therapeutics position peaked at $58K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.